Curable. Inc. (XKON: 086460)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,990.00
+60.00 (2.05%)
Nov 20, 2024, 9:00 AM KST

Curable. Company Description

Curable. Inc. provides single nucleotide polymorphism (SNP) research and analysis services in South Korea. The company offers various services, such as genome analyzer; and sequencing and re-sequencing, immunoprecipitate sequencing, small RNA discovery and analysis, and digital gene expression profiling services.

It also provides SNP genotyping services; SNP discovery services; and microsatellites typing, DNA sequencing, bio-informatics, gene identification, and statistical analysis services.

The company serves pharmaceutical companies. The company was formerly known as SNP Genetics Inc. Curable.

Inc. was founded in 2000 and is headquartered in Hwaseong-si, South Korea.

Curable. Inc.
Country South Korea
Founded 2000
Industry Commercial Physical and Biological Research
Employees 16
CEO Hyoung-Doo Shin

Contact Details

Address:
93 Dongtan-daero 23-gil
Hwaseong-si
South Korea
Phone 82 31 376 1671
Website curablent.com

Stock Details

Ticker Symbol 086460
Exchange Korea New Exchange
Reporting Currency KRW
SIC Code 8731

Key Executives

Name Position
Hyoung-Doo Shin Chief Executive Officer